Pertussis immunization in HIV-1-infected infants: A model to assess the effects of repeated T cell-dependent antigen administrations on HIV-1 progression. Italian Register for HIV infection in children

Vaccine

Volumn 18, Issue 13, 2000, Pages 1203-1209

  Tovo, Pier Angelo ^a   de Martino, Maurizio ^b   Gabiano, Clara ^a   Galli, Luisa ^b   Osimani, P ^c   De Mattia, D ^c   Zizzadoro, P ^c   Ruggeri, M ^c   Masi, M ^c   Dell'Erba, G ^c   Lanari, M ^c   Bosi, I ^c   Chiriaco P G ^c   Duse, M ^c   Crispino, P ^c   Soresina, M R ^c   Bresciani, E ^c   Battisti, L ^c   Pintor, C ^c   Chiappe, F ^c   Belloni, M ^c   Loriano, D ^c   Ibba, P ^c   Berrino, R ^c   Nasi, C ^c   Sticca, M ^c   Palmieri, M ^c   Anastasio, E ^c   Bezzi, T ^c   Vierucci, A ^c   Guarino Amato, A ^c   Farina, S ^c   Cecchi, M T ^c   De Maria, A ^c   Fioredda, F ^c   Donelli, E ^c   Marazzi, M G ^c   Pontali, E ^c   Forni, G L ^c   Cosso, D ^c   Gotta, C ^c   Lobello, D ^c   Tondo, U ^c   Micheletti, E ^c   Ruggeri, C ^c   Plebani, A ^c   Pinzani, R ^c   Salvini, F ^c   Marchisio, P ^c   Esposito, S ^c   Massironi, E ^c   Zuccotti, G V ^c   Riva, E ^c   Gamboni, A ^c   Ferraris, G ^c   Rancilio, L ^c   Vegni, C ^c   Altobelli, R ^c   Lipreri, R ^c   Conio, S ^c   Lizzoli, F ^c   Gambaretto, G ^c   Cellini, M ^c   Pignata, C ^c   Pozzi, N ^c   Guarino, A ^c   Romano, A ^c   Todeschini, A ^c   Giaquinto, C ^c   Ruga, E M ^c   Rampon, O ^c   Consolini, R ^c   Palla, G ^c   Legitimo, A ^c   Benaglia, G ^c   Caselli, D ^c   Maccabruni, A ^c   Pacati, I ^c   Antonellini, A ^c   Metri, A ^c   Magnani, C ^c   Falconieri, P ^c   Fundaro C ^c   Genovese, O ^c   Rendeli, C ^c   Stegagno, M ^c   Castelli Gattinara, G ^c   Bernardi, S ^c   Cancrini, C ^c   Timpano, C ^c   Anzidei, G ^c   Marchili, M R ^c   Catania, S ^c   Ogana, C ^c   Mazza, A ^c   Di Palma, A ^c   Scolfaro, C ^c   Riva, C ^c   Palomba, E ^c   Salvatore, C ^c   more..

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c NONE

Author keywords

Disease progression; Perinatal HIV 1 infection; Pertussis immunization

Indexed keywords

CD4 ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; MODELS, IMMUNOLOGICAL; PERTUSSIS VACCINE; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; VACCINES, INACTIVATED;

EID: 0033986925     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00383-7     Document Type: Article

References (33)

1. Mellors J.W., Rinaldo C.R. Jr, Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
2. Shearer W.T., Quinn T.C., La Russa P., et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. New Engl. J. Med. 336:1997;1337-1342.
3. Ho D.D. HIV-1 viraemia and influenza. Lancet. 339:1992;1549. [letter].
4. Staprans S.I., Hamilton B.L., Follansbee S.E., et al. Activation of virus replication after vaccination of HIV-infected individuals. J. Exp. Med. 182:1995;1727-1737.
5. Stanley S.K., Ostrowski M.A., Justement J.S., et al. Effect of immunization with common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. New Engl. J. Med. 334:1996;1222-1230.
6. O'Brien W.A., Grovit-Ferbas K., Namazi A., et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 86:1995;1082-1089.
7. Rosok B., Voltersvik P., Bjerkenes R., Axelsson M., Haaheim L.R., Asjo B. Dynamic of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin. Exp. Immunol. 104:1996;203-207.
8. Ostrowski M.A., Stanley S.K., Justement J.S., Ganntt K., Goletti D., Fauci A.S. Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. AIDS Res. Hum. Retrov. 13:1997;473-480.
9. Yerly S., Wunderli W., Wyler C.A., et al. Influenza immunization of HIV-l infected patients does not increase HIV-l viral load. AIDS. 8:1994;1503-1504. [letter].
10. Ramilo O., Hicks P.J., Borvak J., et al. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr. Infect. Dis. J. 15:1996;197-203.
11. Gheeseman S.H., Davaro R.E., Ellison R.T. Hepatitis B vaccination and plasma HIV-l RNA. New Engl. J. Med. 334:1996;1272.
12. Fowke K.R., D'Amico R., Chernoff D.N., et al. Immunologic and virologic evaluation after influenza vaccination of HIV-infected patients. AIDS. 11:1997;1013-1021.
13. Jackson C.R., Vavro C.L., Valentine M.E., et al. Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus. Pediatr. Infect. Dis. J. 16:1997;200-204.
14. Donovan R.M., Moore E., Bush C.E., Markowitz N.P., Saravolatz L.D. Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS. 11:1997;1054-1055.
15. de Martino M., Podda A., Galli L., Sinangil F., et al. Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection. Vaccine. 15:1997;1235-1238.
16. Tovo P.A., de Martino M., Gabiano C., et al. Prognostic factors and survival in children with perinatal HIV-l infection. Lancet. 339:1992;1249-1253.
17. Features of children perinatally infected with HIV-l surviving longer than 5 years. Lancet. 343:1994;191-195.
18. Galli L., de Martino M., Tovo P.A., et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS. 9:1995;455-461.
19. Tovo P.A., de Martino M., Gabiano C., et al. Mode of delivery and gestational age influence perinatal HIV-l transmission. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 11:1996;88-94.
20. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children with less than 13 years of age. Morb Mortal Wkly Rep 1994, 43 (RR-12). p. 1-10.
21. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1993, 41 (RR-17). p. 1-19.
22. SPSSX statistical package for the social sciences. 1986;McGraw-Hill, New York.
23. BMDP statistical software. 1981;University of California Press, Los Angeles.
24. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
25. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 34:1972;187-200.
26. Le vaccinazioni nel bambino nato da madre HIV-1 positiva. Riv. Ital. Pediatr. 20:1994;284-288.
27. Zack J.A., Arrigo S.J., Witsman S.R., Go A.S., Haislip A., Chen I.S.Y. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labil, latent viral structure. Cell. 61:1990;213-222.
28. Bukrinsky M.I., Stanwick T.L., Dempsey M.P., Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science. 254:1991;423-427.
29. Blanche S., Mayaux M.-J., Rouzioux C., et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. New Engl. J. Med. 330:1994;308-312.
30. Galli L., de Martino M., Tovo P.A., et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS. 9:1995;455-461.
31. Morbility and mortality in European children vertically infected by HIV-1. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 14:1997;442-450.
32. Immunization of children infected with human T lymphotropic type III-lymphoadenopathy-associated virus. Pediatr. Infect. Dis. J. 6:1987;209-212.
33. Immunization Practices Advisory Committee (ACIP). Prevention and control of influenza part 1 vaccine recommendations of the advisor committee on immunization practices. Morb Mortal Wkly Rep 1993, 42, RR-6.